Table 1
Direct costs estimates, in 2016 million US$.
| TOTAL | DM AS MAIN CAUSE | MORBIDITIES RELATED TO DM | |
|---|---|---|---|
| Hospitalizations | 232.8 | 58.1 | 174.7 |
| Women | 108.6 | 30.4 | 78.2 |
| Men | 124.1 | 27.7 | 96.4 |
| Public | 189.8 | 50.2 | 139.7 |
| Private | 43.0 | 8.0 | 35.0 |
| Ambulatory | 86.0 | 3.9 | 82.1 |
| Women | 49.0 | 1.9 | 47.1 |
| Men | 37.0 | 1.9 | 35.1 |
| Public | 82.5 | 3.5 | 79.0 |
| Private | 3.5 | 0.4 | 3.1 |
| Popular Pharmacy | 304.2 | ||
| Out-of-Pocket Expenses | 10.0 | ||
| Total | 633.0 |
Table 2
Hospitalization and ambulatory costs by age groups, in 2016 million US$.
| DM AS MAIN CAUSE | ATTRIBUTED TO DM | TOTAL | ||||
|---|---|---|---|---|---|---|
| Hospitalizations | 58.1 | 174.7 | 232.8 | |||
| below 18 years old | 3.5 | 6.0% | 3.5 | 1.5% | ||
| 18–34 years old | 7.7 | 13.3% | 7.7 | 3.3% | ||
| 35–44 years old | 6.3 | 10.8% | 3.8 | 2.2% | 10.1 | 4.3% |
| 45–54 years old | 7.6 | 13.1% | 16.2 | 9.3% | 23.8 | 10.2% |
| 55–64 years old | 11.5 | 19.7% | 48.7 | 27.9% | 60.2 | 25.8% |
| 65–74 years old | 11.6 | 19.9% | 60.6 | 34.7% | 72.2 | 31.0% |
| 75 years old and above | 10.0 | 17.3% | 45.4 | 26.0% | 55.4 | 23.8% |
| Ambulatory | 3.9 | 82.1 | 86.0 | |||
| below 18 years old | 0.04 | 1% | 0.04 | 0.05% | ||
| 18–34 years old | 0.2 | 4% | 0.2 | 0.2% | ||
| 35–44 years old | 0.3 | 7% | 2.1 | 2.6% | 2.4 | 2.8% |
| 45–54 years old | 0.7 | 19% | 8.1 | 9.9% | 8.8 | 10.3% |
| 55–64 years old | 1.3 | 34% | 23.5 | 28.6% | 24.8 | 28.8% |
| 65–74 years old | 0.9 | 24% | 31.4 | 38.3% | 32.3 | 37.6% |
| 75 years old and above | 0.4 | 12% | 17.0 | 20.7% | 17.4 | 20.3% |
Table 3
Indirect costs estimates, absenteeism, in 2016 US$ million and % of total.
| TOTAL | DM AS MAIN CAUSE | ATTRIBUTED TO DM | ||||
|---|---|---|---|---|---|---|
| WOMEN | MEN | WOMEN | MEN | |||
| Absenteeism (in million) | 39.80 | 10.20 | 9.59 | 9.52 | 10.49 | |
| below 18 years old | 2.53% | 5.69% | 4.44% | |||
| 18–34 years old | 4.62% | 13.17% | 5.18% | |||
| 35–44 years old | 5.37% | 9.69% | 7.63% | 2.02% | 2.15% | |
| 45–54 years old | 11.43% | 11.92% | 17.34% | 7.70% | 8.95% | |
| 55–64 years old | 23.42% | 18.91% | 26.12% | 21.48% | 27.12% | |
| 75 years old and above | 27.29% | 20.48% | 23.29% | 30.21% | 34.92% | |
Table 4
Indirect costs estimates, premature death, in 2016 US$ million and % of total.
| TOTAL | DM AS MAIN CAUSE | ||
|---|---|---|---|
| WOMEN | MEN | ||
| Premature Death (in million) | 1,183 | 409 | 775 |
| 18–34 years old | 14.38% | 20.07% | 11.38% |
| 35–44 years old | 20.10% | 25.29% | 17.37% |
| 45–54 years old | 38.53% | 40.98% | 37.24% |
| 55–64 years old | 26.99% | 13.66% | 34.02% |
Table 5
Economic burden of DM per patient and per capita, in 2016 values.
| DIRECT COSTS | INDIRECT COSTS | TOTAL | |
|---|---|---|---|
| Total Economic Burden (in million US$) | 633 | 1,520 | 2,153 |
| % of the total | 29.40% | 70.60% | |
| Economic Burden per capita (in US$) | 3.09 | 7.41 | 10.49 |
| Economic Burden per patient (in US$) | 65.72 | 157.81 | 223.54 |
Table 6
Total economic burden (EB) of DM, current (2016) and projected (2030), in 2016 million US$.
| DM PREVALENCE | DM PATIENTS | TOTAL EB | % OF EB | % ANNUAL EB | |
|---|---|---|---|---|---|
| % | N | U$ MILLION | % | % | |
| 2016 values | 6.42% | 9,631,664 | 2,153.05 | ||
| 2030 optimist[1] | 7.90% | 13,695,390 | 3,061.45 | 42.19% | 2.55% |
| 2030 realist[2] | 12.96% | 22,479,515 | 5,025.05 | 133.39% | 6.24% |
[i] Notes:
[1] We consider that DM prevalence changes only due to population aging.
[2] We consider that DM prevalence changes both with population aging and at the same pace it increased from 2003 and 2013.